Albireo   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Gothenburg Sweden (2008)

Organization Overview

First Clinical Trial
2009
NCT01007123
First Marketed Drug
2021
a4250
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Albireo | ALBIREO